NCT06253338 Optimization of Radiation Protection Through Genomic Analyses
| NCT ID | NCT06253338 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Essen |
| Condition | DNA |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2025-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-06-01 with a primary completion date of 2025-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The long-term goal is to define "signatures" in the form of genomic changes through sequence analyses of genomic DNA using modern Next Generation Sequencing (NGS) methods, which 1. determine the radiation exposure of humans. 2. provide information about the exposure (dose). 3. determine the radiation quality. 4. predict the repair capacity and radiation resistance of an individual.
Eligibility Criteria
Inclusion Criteria: ECOG 0/1 no prior treatment no prior cancer diagnosis thoracic or head and neck cancer Exclusion Criteria: prior treatment (chemotherapy, radiotherapy, etc.) prior cancer diagnosis
Frequently Asked Questions
Who can join the NCT06253338 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying DNA. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06253338 currently recruiting?
Yes, NCT06253338 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Hospital, Essen to inquire about joining.
Where is the NCT06253338 trial being conducted?
This trial is being conducted at Essen, Germany.
Who is sponsoring the NCT06253338 clinical trial?
NCT06253338 is sponsored by University Hospital, Essen. The trial plans to enroll 30 participants.